NEWS&TOPICS

2021/02/09 ¸¦µæÀ®²Ì
ºÙ˦¤¬±ÉÍܾõÂ֤˱þ¤¸¤Æ¥¿¥ó¥Ñ¥¯¼Á¤Î¹çÀ®¡¦Ê¬²ò¤òÄ´À᤹¤ë»ÅÁȤߤò²òÌÀ

¿·³ãÂç³ØÂç³Ø±¡°å»õ³ØÁí¹ç¸¦µæ²Êµ¡Ç½À©¸æ³ØʬÌî¤ÎÊ¡ÅÄÃÒ¹Ô½Ú¶µ¼ø¤é¤ÈÆàÎÉÀèü²Ê³Øµ»½ÑÂç³Ø±¡Âç³Ø¥Ð¥¤¥ª¥µ¥¤¥¨¥ó¥¹Îΰè¤Î±öùõ°ì͵¶µ¼ø¤é¤È¤Î¶¦Æ±¸¦µæ¥°¥ë¡¼¥×¤Ï¡¢ºÙ˦Æâ¤Îʪ¼ÁÂå¼Õ¤òÀ©¸æ¤¹¤ë¡ÖTORÊ£¹çÂÎ(1)¡×¤È¤è¤Ð¤ì¤ë¥¿¥ó¥Ñ¥¯¼Á¥ê¥ó»À²½Ê£¹çÂΤγèÀ­¤¬±ÉÍܾõÂ֤˱þ¤¸¤ÆÄ´Àᤵ¤ì¤ë»ÅÁȤߤòÌÀ¤é¤«¤Ë¤·¤Þ¤·¤¿¡£TORÊ£¹çÂΤϺÙ˦¤ÎÏ·²½¤ä¤¬¤ó¤ÎÁý¿£¤Ë¤â´ØÍ¿¤¹¤ë¤³¤È¤¬ÃΤé¤ì¤Æ¤¤¤Þ¤¹¡£Ëܸ¦µæ·ë²Ì¤Ï¡¢ºÙ˦¤Î±ÉÍܱþÅú¤äÂå¼ÕÀ©¸æ¤ÎÍý²ò¤Ë·Ò¤¬¤ë½ÅÍפÊÀ®²Ì¤È¤¤¤¨¤Þ¤¹¡£
¡¡
¡ÚËܸ¦µæÀ®²Ì¤Î¥Ý¥¤¥ó¥È¡Û
¡¦TORÊ£¹çÂΤγèÀ­¤òÄ´À᤹¤ëGATORÊ£¹çÂΤι½À®°ø»Ò¤òƱÄꤷ¤¿¡£
¡¦¥¢¥ß¥Î»À¤Ê¤É¤Î±ÉÍܤ˱þÅú¤·¤ÆTORÊ£¹çÂΤγèÀ­¤¬Ä´Àᤵ¤ì¤ë»ÅÁȤߤòÌÀ¤é¤«¤Ë¤·¤¿¡£
¡¦º£²óÌÀ¤é¤«¤Ë¤·¤¿TORÊ£¹çÂΤγèÀ­Ä´Àá¤ÏºÙ˦¤ÎÁý¿£¤äʬ²½¤Ë½ÅÍפÊÌò³ä¤ò²Ì¤¿¤¹¤³¤È¤¬Ê¬¤«¤Ã¤¿¡£
¡¡
Ⅰ¡¥¸¦µæ¤ÎÇØ·Ê
ºÙ˦¤Ï±ÉÍÜ¡¢¥¹¥È¥ì¥¹¡¢À®Ä¹°ø»Ò¡¢¥¨¥Í¥ë¥®¡¼¤È¤¤¤Ã¤¿ÍÍ¡¹¤Ê¾ðÊó¤Ë±þ¤¸¤ÆÁý¿£¤äʬ²½¤òÀ©¸æ¤·¤Æ¤¤¤Þ¤¹¡£¤³¤¦¤·¤¿À©¸æ¤Ë¤ª¤¤¤Æ»ÊÎáÅãŪ¤ÊÌò³ä¤ò²Ì¤¿¤¹¤Î¤¬¡¢TORÊ£¹çÂΤȤè¤Ð¤ì¤ë¥¿¥ó¥Ñ¥¯¼ÁÊ£¹çÂΤǤ¹¡£TORÊ£¹çÂΤϡ¢¸¶»ÏŪ¤ÊñºÙ˦À¸Êª¤Ç¤¢¤ë¹ÚÊ줫¤é¹âÅù¤Ê¥Ò¥È¤ä¿¢Êª¤Þ¤ÇÁ´¤Æ¤Î¿¿³ËÀ¸Êª¤Ë¶¦Ä̤·¤Æ¸ºß¤¹¤ë¡¢À¸Â¸¤ËÉԲķç¤Ê°ø»Ò¤Ç¤¹¡£±ÉÍܤ¬Ë­É٤ˤ¢¤ë¤ÈTORÊ£¹çÂΤϳèÀ­²½¤·¤Æ¥¿¥ó¥Ñ¥¯¼Á¤Î¹çÀ®¤òÂ¥¿Ê¤·¡¢ºÙ˦¤òÀ®Ä¹¤µ¤»¤Þ¤¹¡£°ìÊý¡¢±ÉÍܵ²²î»þ¤Ë¤ÏTORÊ£¹çÂΤγèÀ­¤¬Äã²¼¤·¤Æ¥¿¥ó¥Ñ¥¯¼Á¤Î¹çÀ®¤¬ÍÞ¤¨¤é¤ì¤ë¤È¤È¤â¤Ë¡¢¥ª¡¼¥È¥Õ¥¡¥¸¡¼(2)¤¬Í¶Æ³¤µ¤ì¤Æ¥¿¥ó¥Ñ¥¯¼Á¤Îʬ²ò¤¬À¸¤¸¤Þ¤¹¡£¤³¤Î¤è¤¦¤Ë¡¢TORÊ£¹çÂΤϱÉÍܾõÂ֤˱þ¤¸¤Æ³èÀ­¤¬ÊÑÆ°¤·¡¢¥¿¥ó¥Ñ¥¯¼Á¤Î¹çÀ®¤Èʬ²ò¤ò¥³¥ó¥È¥í¡¼¥ë¤·¤Æ¤¤¤Þ¤¹¡£TORÊ£¹çÂΤϱÉÍܤòľÀÜ´¶ÃΤ¹¤ë¤³¤È¤Ï¤Ç¤­¤Þ¤»¤ó¡£¤½¤³¤Ç¡¢±ÉÍܾõÂ֤˴ؤ¹¤ë¾ðÊ󤬤ɤΤ褦¤ËTORÊ£¹çÂΤؤÈÅÁ¤¨¤é¤ì¤ë¤Î¤«¤Ë´Ø¤·¤Æ¡¢¥Ò¥ÈºÙ˦¤ò¤Ï¤¸¤áÍÍ¡¹¤ÊÀ¸Êª¼ï¤òÍѤ¤¤Æ¸¦µæ¤¬¹Ô¤ï¤ì¤Æ¤¤¤Þ¤¹¡£
¡¡
Ⅱ¡¥¸¦µæ¤Î³µÍ×
Ëܸ¦µæ¥°¥ë¡¼¥×¤ÏʬÎö¹ÚÊì(3)¤ò¸¦µæºàÎÁ¤ËÍѤ¤¡¢TORÊ£¹çÂΤγèÀ­¤òÄ´À᤹¤ë°ø»Ò¤òõº÷¤·¤Þ¤·¤¿¡£¤Þ¤º¡¢¥Ò¥ÈºÙ˦¤Ë¤ª¤¤¤ÆTORÊ£¹çÂΤγèÀ­¤òÀ©¸æ¤¹¤ë¤³¤È¤¬´û¤ËÃΤé¤ì¤Æ¤¤¤ëGATORÊ£¹çÂÎ(4)¤¬¡¢Ê¬Îö¹ÚÊì¤Ë¤â¸ºß¤¹¤ë¤³¤È¤ò¸«¤¤¤À¤·¤Þ¤·¤¿¡£¥Ò¥È¤ÈʬÎö¹ÚÊì¤Î´Ö¤ÇGATORÊ£¹çÂΤι½À®¤Ï´°Á´¤Ë°ìÃפ·¤Æ¤¤¤Þ¤·¤¿¤¬¡¢¹½À®°ø»Ò¤Îµ¡Ç½¤ËÁê°ã¤¬¸«¤é¤ì¤Þ¤·¤¿¡£¼¡¤Ë¡¢Ê¬Îö¹ÚÊ줬±ÉÍÜÁǤΤҤȤĤǤ¢¤ë¥¢¥ß¥Î»À¤Î̵ͭ¤òǧ¼±¤·¤ÆTORÊ£¹çÂΤ˾ðÊó¤òÅÁ㤹¤ëµ¡¹½¤ò²òÀϤ·¤Þ¤·¤¿¡£¤½¤Î·ë²Ì¡¢Gcn2(5)¤È¤¤¤¦¥¿¥ó¥Ñ¥¯¼Á¤¬¥¢¥ß¥Î»À¤Î·ç˳¤ò´¶ÃΤ·¡¢Å¾¼Ì°ø»Ò¤Îȯ¸½Í¶Æ³¤ò²ð¤·¤Æ¡¢TORÊ£¹çÂΤγèÀ­¤òÍÞ¤¨¤ë¤³¤È¤¬Ê¬¤«¤ê¤Þ¤·¤¿¡Ê¿Þ1¡Ë¡£°ìÊý¡¢ÃâÁǸ»¤ò±ÉÍÜÁǤȤ·¤Æǧ¼±¤·¤ÆTORÊ£¹çÂΤËÅÁ¤¨¤ë¾ì¹ç¤Ë¤Ï¡¢Gcn2¤ÈGATORÊ£¹çÂΤ˲䨤ơ¢TSCÊ£¹çÂÎ(6)¤â´Þ¤á¤¿»°¤Ä¤Î°ø»Ò¤¬¡¢¤½¤ì¤¾¤ìÆÈΩ¤ËºîÍѤ·¤Æ¤¤¤ë¤³¤È¤¬Ê¬¤«¤ê¤Þ¤·¤¿¡Ê¿Þ2¡Ë¡£¤µ¤é¤Ë¡¢¤³¤ì¤é»°°ø»Ò¤Ë¤è¤ëTORÊ£¹çÂΤγèÀ­Ä´À᤬Àµ¾ï¤Ë¹Ô¤¨¤Ê¤¤Ê¬Îö¹ÚÊì¤Ï¡¢±ÉÍܤ¬Ë­É٤ˤ¢¤Ã¤Æ¤âÁý¿£¤¬ÃÙ¤¯¡¢±ÉÍܵ²²î¾ò·ï²¼¤ÇͶƳ¤µ¤ì¤ë˦»Ò·ÁÀ®¤Î¸úΨ¤¬Ä㤤¤È¤¤¤Ã¤¿À¸Íýµ¡Ç½¤ÎÄã²¼¤¬¸«¤é¤ì¤Þ¤·¤¿¡£

Ⅲ¡¥¸¦µæ¤ÎÀ®²Ì
ʬÎö¹ÚÊì¤ÎºÙ˦¤Ç¤Ï¡¢±ÉÍܤμïÎà¤Ë±þ¤¸¤ÆGATORÊ£¹çÂΡ¢Gcn2¡¢TSCÊ£¹çÂΤλ°°ø»Ò¤¬¤½¤ì¤¾¤ìÆÈΩ¤ËºîÍѤ·¤ÆTORÊ£¹çÂΤγèÀ­¤òÄ´Àᤷ¡¢¥¿¥ó¥Ñ¥¯¼Á¤Î¹çÀ®¤Èʬ²ò¤òÀ©¸æ¤·¤Æ¤¤¤ë¤³¤È¤¬ÌÀ¤é¤«¤Ë¤Ê¤ê¤Þ¤·¤¿¡£¤Þ¤¿¡¢¤³¤¦¤·¤¿À©¸æ¤¬Ê¬Îö¹ÚÊì¤ÎÁý¿£¤äʬ²½¤Î¥³¥ó¥È¥í¡¼¥ë¤Ë½ÅÍפÊÌò³ä¤ò²Ì¤¿¤·¤Æ¤¤¤ë¤³¤È¤¬Ê¬¤«¤ê¤Þ¤·¤¿¡£¤³¤ì¤é¤Î»°°ø»Ò¤Ï¤¤¤º¤ì¤â¥Ò¥ÈºÙ˦¤Ë¤â¸ºß¤·¤Æ¤¤¤Þ¤¹¤¬¡¢Ê¬Îö¹ÚÊì¤È¥Ò¥ÈºÙ˦¤È¤Î´Ö¤Ç±ÉÍܤÎǧ¼±¤ä¾ðÊóÅÁã¤ÎÍͼ°¤Ëº¹°Û¤â¸«¤é¤ì¤Þ¤·¤¿¡£¤½¤Î¤¿¤á¡¢¿¿³ËÀ¸Êª¤Ï¶¦Ä̤·¤¿Ê¬»ÒÁõÃÖ¤òÍѤ¤¤Ê¤¬¤é¤â¡¢³ÆÀ¸Êª¼ï¤ÎÆÃÀ­¤ä´Ä¶­¤ËŬ¤·¤¿Â¿ÍͤÊÊýË¡¤ÇTORÊ£¹çÂΤγèÀ­¤òÄ´Àᤷ¤Æ¤¤¤ë²ÄǽÀ­¤¬¼¨¤µ¤ì¤Þ¤·¤¿¡£
¡¡
Ⅳ¡¥º£¸å¤ÎŸ³«
TORÊ£¹çÂΤÏÈùÀ¸Êª¤«¤é¥Ò¥È¤Þ¤ÇÍÍ¡¹¤ÊÀ¸Êª¤Ë¤ª¤¤¤ÆºÙ˦Æâ¤Îʪ¼ÁÂå¼Õ¤ò¥³¥ó¥È¥í¡¼¥ë¤·¤Æ¤¤¤Þ¤¹¡£¤Þ¤¿¡¢TORÊ£¹çÂΤϤ¬¤ó¤ÎÁý¿£¤òÂ¥¿Ê¤¹¤ë¤¿¤á¡¢¤½¤ÎÁ˳²ºÞ¤¬¹³´âºÞ¤È¤·¤ÆÍ­¸ú¤Ç¤¢¤ë¤³¤È¤¬ÃΤé¤ì¤Æ¤¤¤Þ¤¹¡£¤·¤¿¤¬¤Ã¤Æ¡¢TORÊ£¹çÂΤγèÀ­À©¸æ¤ÎÍý²ò¤¬¤µ¤é¤Ë¿¼¤Þ¤ê¡¢³èÀ­¤ò¿Í°ÙŪ¤ËÁàºî¤Ç¤­¤ë¤è¤¦¤Ë¤Ê¤ì¤Ð¡¢ÈùÀ¸Êª¤òÍѤ¤¤¿Êª¼ÁÀ¸»º¤Î¸þ¾å¤ä¡¢¤¬¤ó¤Î¸ú²ÌŪ¤Ê¼£ÎÅË¡¤Ë¤Ä¤Ê¤¬¤ë¤È´üÂÔ¤µ¤ì¤Þ¤¹¡£
¡¡
Ⅴ¡¥¸¦µæÀ®²Ì¤Î¸øɽ
¤³¤ì¤é¤Î¸¦µæÀ®²Ì¤Ï¡¢2021ǯ2·î3Æü¡¢eLife»ï¤Ë·ÇºÜ¤µ¤ì¤Þ¤·¤¿¡£
ÏÀʸ¥¿¥¤¥È¥ë¡§Tripartite suppression of fission yeast TORC1 signaling by the GATOR1-Sea3 complex, the TSC complex, and Gcn2 kinase
Ãø¼Ô¡§Tomoyuki Fukuda, Fajar Sofyantoro, Yen Teng Tai, Kim Hou Chia, Takato Matsuda, Takaaki Murase, Yuichi Morozumi, Hisashi Tatebe, Tomotake Kanki, Kazuhiro Shiozaki
doi:10.7554/eLife.60969.¡Êhttps://elifesciences.org/articles/60969¡Ë
¡¡
¡¡
¡üÍѸì¤Î²òÀâ
(1) TORÊ£¹çÂΡ§¿¿³ËÀ¸Êª¤Ë¹­¤¯Êݸ¤µ¤ì¤¿¥¿¥ó¥Ñ¥¯¼Á¥ê¥ó»À²½¹ÚÁÇÊ£¹çÂΡ£TOR¡ÊTarget of rapamycin¡Ë¥­¥Ê¡¼¥¼¤ò´Þ¤àÊ£¿ô¤Î¥¿¥ó¥Ñ¥¯¼Á¤Ç¹½À®¤µ¤ì¤Þ¤¹¡£ºÙ˦Æâ¤ÎÍÍ¡¹¤Ê¥¿¥ó¥Ñ¥¯¼Á¤ò¥ê¥ó»À²½¤¹¤ë¤³¤È¤Ç¡¢¤½¤ì¤é¤Îµ¡Ç½¤òÀ©¸æ¤·¤Þ¤¹¡£ºÙ˦¤ÎÀ®Ä¹¡¢Áý¿£¡¢Âå¼Õ¡¢Ï·²½¡¢¼÷Ì¿¤Ê¤É¿¤¯¤ÎÀ¸Ì¿¸½¾Ý¤Ë´ØÍ¿¤·¤Æ¤¤¤Þ¤¹¡£
(2) ¥ª¡¼¥È¥Õ¥¡¥¸¡¼¡§ºÙ˦À®Ê¬¤òµå¾õ¤ÎË칽¤¤ÇÊñ¤ß¹þ¤ß¡¢Ê¬²ò¹ÚÁǤˤè¤Ã¤ÆÄãʬ»Ò¤Ø¤Èʬ²ò¤¹¤ëÈ¿±þ¡£¥ª¡¼¥È¥Õ¥¡¥¸¡¼¤Ë¤è¤ê¥¿¥ó¥Ñ¥¯¼Á¤Ï¥¢¥ß¥Î»À¤Ëʬ²ò¤µ¤ì¡¢±ÉÍܤȤ·¤ÆºÆÍøÍѤµ¤ì¤Þ¤¹¡£
(3) ʬÎö¹ÚÊ졧ʬÎö¤Ë¤è¤êÁý¿£¤¹¤ë¹ÚÊì¡£¼ç¤Ë´ðÁø¦µæ¤ËÍѤ¤¤é¤ì¤Æ¤ª¤ê¡¢ºÙ˦Áý¿£¤ò¤Ï¤¸¤á¤È¤¹¤ë¿ÍͤÊÀ¸Ì¿¸½¾Ý¤Î¥á¥«¥Ë¥º¥à¤Î²òÌÀ¤Ë¹×¸¥¤·¤Æ¤¤¤Þ¤¹¡£
(4) GATORÊ£¹çÂΡ§GATOR1¤ÈGATOR2¤ÎÆó¤Ä¤ÎÉôʬʣ¹çÂΤ«¤é¤Ê¤ë¥¿¥ó¥Ñ¥¯¼ÁÊ£¹çÂΡ£Ó®ÆýÎàºÙ˦¤Ç¤Ï¼ç¤ËºÙ˦Æâ¤Î¥¢¥ß¥Î»À¤Î¥·¥°¥Ê¥ë¤òTORÊ£¹çÂΤËÅÁ¤¨¤Þ¤¹¡£¤Þ¤¿¡¢Â¿¼ï¤Î¤¬¤óºÙ˦¤ÇGATORÊ£¹çÂι½À®°ø»Ò¤¬·ç»¤·¡¢TORÊ£¹çÂΤγèÀ­¤òÍÞ¤¨¤é¤ì¤Ê¤¯¤Ê¤Ã¤Æ¤¤¤Þ¤¹¡£
(5) Gcn2¡§¥¢¥ß¥Î»À¤Î·ç˳¤òǧ¼±¤¹¤ë¥¿¥ó¥Ñ¥¯¼Á¥ê¥ó»À²½¹ÚÁÇ¡£¥¿¥ó¥Ñ¥¯¼Á¹çÀ®¤Ë´Ø¤ï¤ë°ø»Ò¤ò¥ê¥ó»À²½¤¹¤ë¤³¤È¤Ç¡¢¥¿¥ó¥Ñ¥¯¼Á¹çÀ®¤äž¼Ì°ø»Ò¤Îȯ¸½Í¶Æ³¤òÀ©¸æ¤·¤Þ¤¹¡£
(6) TSCÊ£¹çÂΡ§TORÊ£¹çÂΤγèÀ­Ä´Àá¤Ë´Ø¤ï¤ë¥¿¥ó¥Ñ¥¯¼ÁÊ£¹çÂΡ£·ëÀáÀ­¹Å²½¾É´µ¼Ô¤Ë¤ª¤¤¤Æ¹½À®°ø»Ò¤ËÊÑ°Û¤¬¸«¤é¤ì¤Þ¤¹¡£Ó®ÆýÎàºÙ˦¤Ç¤ÏÀ®Ä¹°ø»Ò¤äºÙ˦Æ⥨¥Í¥ë¥®¡¼¤Î¾ðÊó¤òTORÊ£¹çÂΤËÅÁ¤¨¤Þ¤¹¡£
¡¡
¡¡
ËÜ·ï¤Ë´Ø¤¹¤ë¤ªÌ䤤¹ç¤ï¤»Àè
¿·³ãÂç³ØÂç³Ø±¡°å»õ³ØÁí¹ç¸¦µæ²Êµ¡Ç½À©¸æ³ØʬÌî
½Ú¶µ¼ø¡¡Ê¡ÅÄÃҹԡʤդ¯¤À¡¡¤È¤â¤æ¤­¡Ë
E-mail¡§tfukuda@med.niigata-u.ac.jp

ºÇ¿·¤Îµ­»ö ¢«¿·µ­»ö °ìÍ÷¤ØÌá¤ë Á°µ­»ö¢ª ºÇ½é¤Îµ­»ö